Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
JCR Pharmaceuticals Co., Ltd. (JP:4552)
TSE/TYO:4552
RESEARCH TOOLSreports
Holding JP:4552?
Track your performance easily
4552 Stock Chart & Stats
Day’s Range¥0 - ¥0
52-Week Range¥466.00 - ¥1,339.00
Previous Close¥724
Volume610.40K
Average Volume (3M)400.87K
Market Cap
¥89.60B
Enterprise ValueN/A
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)―
Beta1.01
Next Earnings
Jan 30, 2025EPS Estimate
¥2.15Next Dividend Ex-Date
Mar 28, 2025Dividend Yield2.87%
Share Statistics
EPS (TTM)-3.49
Shares OutstandingN/A
10 Day Avg. VolumeN/A
30 Day Avg. Volume400,873
Standard DeviationN/A
R-SquaredN/A
AlphaN/A
Financial Highlights & Ratios
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
¥665.00Price Target Upside-8.15% Downside
Rating ConsensusHold
Number of Analyst Covering2
JCR Pharmaceuticals Co., Ltd. News
PremiumCompany Announcements
JCR Pharmaceuticals Faces Financial Decline Amid Strategic Changes
PremiumCompany Announcements
JCR Pharmaceuticals Completes Share Buyback for Strategic Growth
PremiumCompany Announcements
JCR Pharmaceuticals Begins Trials for Rare Disorder Treatment
PremiumCompany Announcements
JCR Pharmaceuticals Reports Decline Amid Subsidiary Changes
PremiumCompany Announcements
JCR Pharmaceuticals to Repurchase Shares for Capital Efficiency
PremiumCompany Announcements
JCR Pharmaceuticals Boosts Leadership Amid Global Expansion
PremiumCompany Announcements
JCR Pharmaceuticals Declares Interim Dividend Amid Growth FocusPremiumCompany Announcements
JCR Pharmaceuticals Advances Gene Therapy ResearchOptions Prices
Currently, No data available
---
Ownership Overview
―
Insiders
1.40% Mutual Funds
― Other Institutional Investors
96.62% Public Companies and
Individual Investors
4552 FAQ
What was JCR Pharmaceuticals Co., Ltd.’s price range in the past 12 months?
JCR Pharmaceuticals Co., Ltd. lowest stock price was ¥466.00 and its highest was ¥1339.00 in the past 12 months.
What is JCR Pharmaceuticals Co., Ltd.’s market cap?
Currently, no data Available
When is JCR Pharmaceuticals Co., Ltd.’s upcoming earnings report date?
JCR Pharmaceuticals Co., Ltd.’s upcoming earnings report date is Jan 30, 2025 which is in 67 days.
How were JCR Pharmaceuticals Co., Ltd.’s earnings last quarter?
JCR Pharmaceuticals Co., Ltd. released its earnings results on Oct 30, 2024. The company reported -¥7.14 earnings per share for the quarter, missing the consensus estimate of ¥13.72 by -¥20.86.
Is JCR Pharmaceuticals Co., Ltd. overvalued?
According to Wall Street analysts JCR Pharmaceuticals Co., Ltd.’s price is currently Overvalued.
Does JCR Pharmaceuticals Co., Ltd. pay dividends?
JCR Pharmaceuticals Co., Ltd. pays a Annually dividend of ¥10 which represents an annual dividend yield of 2.87%. See more information on JCR Pharmaceuticals Co., Ltd. dividends here
What is JCR Pharmaceuticals Co., Ltd.’s EPS estimate?
JCR Pharmaceuticals Co., Ltd.’s EPS estimate is ¥2.15.
How many shares outstanding does JCR Pharmaceuticals Co., Ltd. have?
JCR Pharmaceuticals Co., Ltd. has 129,686,310 shares outstanding.
What happened to JCR Pharmaceuticals Co., Ltd.’s price movement after its last earnings report?
JCR Pharmaceuticals Co., Ltd. reported an EPS of -¥7.14 in its last earnings report, missing expectations of ¥13.72. Following the earnings report the stock price went down -0.305%.
Which hedge fund is a major shareholder of JCR Pharmaceuticals Co., Ltd.?
Currently, no hedge funds are holding shares in JP:4552
---
JCR Pharmaceuticals Co., Ltd. Stock Smart Score
4552 Stock 12 Month Forecast
Average Price Target
¥665.00
▼(-8.15% Downside)
Technical Analysis
---